Crossmark

Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition

Crossref DOI link: https://doi.org/10.1186/s13195-017-0248-8

Published Online: 2017-03-22

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Park, Jong-Chan

Han, Sun-Ho

Cho, Hyun Jin

Byun, Min Soo

Yi, Dahyun

Choe, Young Min

Kang, Seokjo

Jung, Eun Sun

Won, Su Jin

Kim, Eun Hye

Kim, Yu Kyeong

Lee, Dong Young

Mook-Jung, Inhee
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2015R1A2A1A05001794)

National Research Foundation of Korea (2014M3C-7A1046047)

National Research Foundation of Korea (2011-0030738)

National Research Foundation of Korea (2014M3C7A1046042)

National Research Foundation of Korea (2015R1C1A2A01053545)

SNU medical school (800-20130066)

SNU medical school (800-20130067)